1. Home
  2. RPC vs INMD Comparison

RPC vs INMD Comparison

Compare RPC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RPC

Ridgepost Capital Inc. Class A Common Stock

N/A

Current Price

$7.74

Market Cap

905.4M

Sector

Finance

ML Signal

N/A

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$13.35

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPC
INMD
Founded
1992
2008
Country
United States
Israel
Employees
326
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
905.4M
842.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RPC
INMD
Price
$7.74
$13.35
Analyst Decision
Buy
Hold
Analyst Count
1
5
Target Price
$11.00
$17.33
AVG Volume (30 Days)
327.0K
610.7K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.96%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.82
$1.74
Revenue Next Year
$15.80
$3.26
P/E Ratio
$53.06
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$12.72
52 Week High
$9.32
$16.74

Technical Indicators

Market Signals
Indicator
RPC
INMD
Relative Strength Index (RSI) 37.14 39.33
Support Level $7.57 $13.29
Resistance Level $7.98 $13.87
Average True Range (ATR) 0.35 0.19
MACD -0.06 -0.02
Stochastic Oscillator 12.31 19.79

Price Performance

Historical Comparison
RPC
INMD

About RPC Ridgepost Capital Inc. Class A Common Stock

Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue mainly comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: